SDC2 is a member of the syndecan family and has been reported to play a critical role either as a tumor suppressor, such as in osteosarcoma (Mansouri et al., 2015), or as an oncogene, such as in breast cancer (Loftus et al., 2021). Here, SDC1 is linked to neoplasm.